Product Images Aripiprazole
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Aripiprazole NDC 70518-2163 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Remedy_Label - Remedy Label

This is information about Aripiprazole 5mg tablets, with a quantity of 30 tablets per pack. The medication is prescribed for use and it is important to keep it away from children. The manufacturer is Camber Pharma, Inc located in Piscataway, NJ. The medication should be stored at a temperature between 20-25°C (58-77°F). It is repackaged by Remedy Repack Inc., located in Indiana, PA. For detailed instructions on the usage, refer to the package insert.*
Figure1 - figure1

The text provided contains information about the effect of other drugs on aripiprazole, specifically related to its pharmacokinetics. It mentions different drug interactions such as CYP3A inhibitor (ketoconazole), CYP2D6 inhibitor (paroxetine), CYP3A inducer (carbamazepine), gastric acid blockers (famotidine), and other miscellaneous drugs like valproate, lorazepam, and more. Each drug interaction is discussed in terms of its impact on aripiprazole concentration (AUC) with 90% confidence intervals provided. This information can be helpful in understanding how these drugs may influence the levels of aripiprazole in the body when used concomitantly.*
Figure4 - figure4

This text provides information on special populations related to gender, age, hepatic impairment, and renal impairment in the context of evaluating the effects of Aripiprazole on metabolizers. It also mentions a comparison of change and confidence interval associated with the drug.*
figure9

This text provides information on the least squares mean change in the YGTSS Total TIC Score. It compares the change in the YGTSS Total TIC score from baseline for ABILIFY LOW, ABILIFY HIGH, and PLACEBO groups. This data may be part of a clinical study or research analysis on the effects of these treatments on tic disorders.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.